ANEBULO PHARMACEUTICALS, INC. Class of Warrant or Right, Outstanding
ANEBULO PHARMACEUTICALS, INC. (ANEB) had Class of Warrant or Right, Outstanding of 1 shares as of 2022-09-28, per its 10-Q filed 2025-05-13.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2025-05-13
- 2022-09-28: Class of Warrant or Right, Outstanding 1.00 shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2022-09-28 | 1.00 shares 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |